(Q34005782)

30 July 2017

1 reference

title

Cannabis and psychosis: what is the link? (English)

1 reference

30 July 2017

1 reference

2

0 references

author name string

Mohamed Ben Amar

series ordinal

1

1 reference

30 July 2017

1 June 2007

1 reference

Journal of Psychoactive Drugs

30 July 2017

1 reference

30 July 2017

39

1 reference

30 July 2017

2

1 reference

30 July 2017

131-142

1 reference

Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders.

30 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis and psychosis: how important is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis psychosis following bhang ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Confounding in epidemiological studies: why "independent" effects may not be all they seem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Testing hypotheses about the relationship between cannabis use and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Tests of causal linkages between cannabis use and psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis and psychosis: accumulating evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use predicts future psychotic symptoms, and vice versa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Marijuana's interaction with brain reward systems: update 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use and psychosis: a review of clinical and epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Epidemiology of schizophrenia: the global burden of disease and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Psychiatric effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Prevalence and correlates of self-reported psychotic symptoms in the British population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis-associated psychosis: current status of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Pathology, phenomenology and the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Influence of cannabis abuse on schizophrenic psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis as a risk factor for psychosis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use and the risk of later schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis and psychosis: extending the debate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Psychiatric effects of hashish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

A community survey of adverse effects of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Stimulant-induced psychosis and schizophrenia: the role of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis use and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Cannabis induced dopamine release: an in-vivo SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

Does dopamine sensitization underlie the association between schizophrenia and drug abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399871

10.1080/02791072.2007.10399871

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

17703707